RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Avecho Biotechnology Stock

Avecho Biotechnology Market capitalization 2024

Avecho Biotechnology Market capitalization

6.8 M AUD

Ticker

AVE.AX

ISIN

AU0000047441

WKN

A2PLEV

In 2024, Avecho Biotechnology's market cap stood at 6.8 M AUD, a -38.29% increase from the 11.03 M AUD market cap in the previous year.

The Avecho Biotechnology Market capitalization history

YEARMarket Capitalization (undefined AUD)
20236.8
202224.36
202134.63
202012.79
20196.29
201824.86
201723.16
201622.71
201539.4
2014101.46
2013123.75
2012141.79
2011-
2010-
2009-
2008-
2007-
2006-
2005-
2004-

Avecho Biotechnology Aktienanalyse

What does Avecho Biotechnology do?

Avecho Biotechnology Ltd is a company specializing in the research of technologies to make active ingredients in the cosmetics industry more effective. The company was founded in 2008 by Dr. Timo Roiko-Jokela and is headquartered in Oxfordshire, England. Avecho's business model is based on the innovation of active ingredient technologies. The company has developed a unique technology called Invisicare® that is able to release active ingredients over a longer period of time, resulting in higher effectiveness in application. This technology also allows for better transportation of the active ingredients through the skin while protecting the skin barrier. Avecho Biotechnology has various divisions that focus on different areas of the cosmetics industry, including skincare, sunscreens, haircare, oral care, and body care. Within these divisions, the company offers various products based on the Invisicare® technology, including creamy lotions, serums, sunscreens, and shampoos. One example product from Avecho is the SolarCare range of sun care products, which are able to protect the skin from the harmful effects of UV rays while moisturizing the skin. Another example is the SkinPep range, which is specifically tailored to the needs of the skin and has high effectiveness due to its unique formula and technology. Avecho's innovations and products are utilized by a variety of cosmetics companies and brands. The company works closely with its customers to develop customized products that are tailored to their individual requirements. In recent times, Avecho has expanded its research and development efforts in the field of dermatology. The company is working to find innovative solutions for skin conditions such as psoriasis, eczema, and acne. The Invisicare® technology from Avecho is a key element in improving the effectiveness of active ingredients and protecting the skin barrier. Overall, Avecho Biotechnology is an innovative company specializing in the development of technologies and products in the cosmetics and dermatology industry. With its unique Invisicare® technology, the company provides customized solutions for the individual needs of its customers. Avecho Biotechnology ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Market capitalization Details

Exploring Avecho Biotechnology's Market Capitalization

Avecho Biotechnology's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Avecho Biotechnology's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Avecho Biotechnology's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Avecho Biotechnology’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Avecho Biotechnology stock

What is the current Avecho Biotechnology market capitalization?

The current market capitalization of Avecho Biotechnology is 6.8 M AUD.

What is market capitalization?

The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Avecho Biotechnology.

How has the market capitalization of Avecho Biotechnology developed in recent years?

The market capitalization of Avecho Biotechnology has increased/decreased by -38.29% compared to the previous year.

What does market capitalization mean for investors?

The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.

Why is market capitalization an important indicator for investors?

The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.

Why does the market capitalization fluctuate?

The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.

What role does market capitalization play in the valuation of Avecho Biotechnology?

In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.

Does the market capitalization influence the performance of Avecho Biotechnology?

There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

Does the market capitalization of Avecho Biotechnology have an influence on indices?

Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).

How much dividend does Avecho Biotechnology pay?

Over the past 12 months, Avecho Biotechnology paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Avecho Biotechnology is expected to pay a dividend of 0 AUD.

What is the dividend yield of Avecho Biotechnology?

The current dividend yield of Avecho Biotechnology is .

When does Avecho Biotechnology pay dividends?

Avecho Biotechnology pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Avecho Biotechnology?

Avecho Biotechnology paid dividends every year for the past 0 years.

What is the dividend of Avecho Biotechnology?

For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Avecho Biotechnology located?

Avecho Biotechnology is assigned to the 'Health' sector.

Wann musste ich die Aktien von Avecho Biotechnology kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Avecho Biotechnology from 6/6/1997 amounting to 0.02 AUD, you needed to have the stock in your portfolio before the ex-date on 5/14/1997.

When did Avecho Biotechnology pay the last dividend?

The last dividend was paid out on 6/6/1997.

What was the dividend of Avecho Biotechnology in the year 2023?

In the year 2023, Avecho Biotechnology distributed 0 AUD as dividends.

In which currency does Avecho Biotechnology pay out the dividend?

The dividends of Avecho Biotechnology are distributed in AUD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Avecho Biotechnology

Our stock analysis for Avecho Biotechnology Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Avecho Biotechnology Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.